259 results
Page 2 of 13
8-K
EX-99.1
nhuq6vlbpp gj9g6jrwk
3 Aug 22
Ampio Pharmaceuticals’ Chairman of the Board Kevin Buchi and CEO Mike Martino Issues Letter to Stockholders
8:36am
8-K
EX-99.1
o5itfkkhsz7
2 Jun 22
Ampio Pharmaceuticals’ CEO Mike Martino Issues Letter to Stockholders
4:35pm
8-K
EX-99.2
kq41390sm 78tp7sd8
16 May 22
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
p36yvelvr4 9lnbf
16 May 22
Results of Operations and Financial Condition
12:00am
8-K
zq0hrc760edk6u1jiwe
28 Apr 22
Conference Call Script
8:00am
8-K
EX-99.1
pstv20wy7rvjrofqw3lw
20 Apr 22
Ampio Provides Regulatory Update
9:43pm
8-K
EX-99.1
z2abrc5i
29 Mar 22
Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights
4:17pm
8-K
EX-99.1
qel cn7ih
2 Mar 22
Complete analysis of AP-013 data show Ampion reduced pain with statistical significance
4:38pm
8-K
EX-99.1
5xonka8po5ht tepp
10 Feb 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
xb77p 9otk
16 Dec 21
Regulation FD Disclosure
4:01pm
8-K
EX-99.1
ol48 6niup
15 Dec 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
go7sub
15 Dec 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
j408l9sd ok1rzg4wt
15 Dec 21
Entry into a Material Definitive Agreement
12:00am
424B5
7x6 eu7chogomnr3ba5
14 Dec 21
Prospectus supplement for primary offering
5:06pm
8-K
EX-10.1
ncseshuv9ph7qeyn4zee
29 Nov 21
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.1
crt4kkdn9scng6
29 Nov 21
Departure of Directors or Certain Officers
4:01pm